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Sunday, February 21, 2010 119aof G601S-hERG. After nocodazole treatment the G601S-hERG immunostain-
ing pattern changed from perinuclear to one that consisted of focal aggregates
located throughout the cytosol. Nocodazole treatment also increased the
glycolytic processing of G601S-hERG similar to that of wild-type hERG. In
contrast, nocodazole treatment did not alter the immunostaining or glycolytic
processing of R752W-hERG. These data suggest that the tdLQT2 phenotype
for G601S-hERG but not R752W-hERG is regulated by microtubule function.
We conclude that microtubule dependent and independent mechanisms may
regulate the tdLQT2 phenotype.
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Homomeric and heteromeric complexes formed by members of the Kv3 sub-
family of voltage-gated potassium (Kv) channel alpha subunits generate cur-
rents essential for the high-frequency firing of mammalian neurons. Kv3.1
and Kv3.2 alpha subunits generate delayed rectifier currents, whereas Kv3.4
generates fast-inactivating currents. This ‘N-type’ fast-inactivation occurs via
an N-terminal ‘ball’ domain, which blocks the channel pore directly after open-
ing, preventing Kþ ion flux. Heteromeric channels containing Kv3.4 with either
Kv3.1 or Kv3.2 exhibit N-type inactivation with a rate dependent upon the
number of Kv3.4 alpha subunits in the tetramer. As Kv channel inactivation
and inactivation recovery rates are important determinants of excitable cell ac-
tion potential morphology and refractory period duration, the stoichiometry of
these heteromeric complexes is expected to be tightly regulated. Here, using
channel subunits cloned from rat and transiently expressed in CHO cells, we
show that Kv3.4 current is significantly suppressed (>90%) by the ancillary
beta subunit MinK (KCNE1) and that the suppression can be rescued by co-
expression of Kv3.1. Through use of dominant-negative pore mutants and
N-terminal A and B box (NAB) intra-subfamily binding domain mutants, we
demonstrate that MinK ensures that Kv3.4 alpha subunits can only reach the
surface as part of a heteromeric complex with Kv3.1. Thus, by acting as
a molecular matchmaker, MinK governs Kv channel inactivation rate and,
potentially, cellular excitability and refractory periods.
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The human Ether-a-go-go Related Gene (hERG) Kþ channel is linked to type 2
Long QT Syndrome (LQT2), and most LQT2mutations decrease hERG current
(IhERG). Since LQT2 follows an autosomal dominant inheritance pattern,
increasing the functional expression of WT-hERGmay have therapeutic poten-
tial. The goal of this study was to identify ways to increase IhERG without alter-
ing gating. We tested the hypothesis that nocodazole (noc), an antimicrotubule
agent, and cytochalasin D (cytoD), an antimicrofilament agent, would increase
IhERG because they can alter the kinetics of protein trafficking to and from the
membrane. We cultured HEK293 cells stably expressing WT-hERG in noc
(20˛1/4M) or cytoD (5˛1/4M) for 18-22 hours and measured IhERG using
the whole-cell patch clamp technique. Using a holding potential of 80 mV,
cells were pre-pulsed to 50 mV in 10 mV increments for 5 seconds, followed
by a test-pulse to50 mV for 5 seconds for control, noc, or cytoD treated cells.
The peak IhERG measured during test-pulse was plotted as a function of the pre-
pulse. The data were described using a Boltzmann equation to calculate the
maximal current density (IMAX), midpoint potential for activation (V1/2), and
the slope factor (k) for IhERG activation. Noc treatment did not alter any of these
parameters. CytoD treatment increased IMAX (control=9358 pA/pF, n=5; cy-
toD=156515 pA/pF, n=7) but did not alter not V1/2 or k. CytoD also did not
alter the voltage-dependent rates of IhERG deactivation (n=6, per group). These
data suggest that the functional expression of WT-hERG is increased by inhi-
bition of microfilaments but not microtubules. We conclude that targeting mi-
crofilaments and/or microfilament-dependent proteins may represent a novel
strategy for increasing the functional expression of WT-hERG without altering
IhERG function.
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2University of Wisconsin-Madison, Madison, WI, USA.The majority of hERG screens aiming to minimize the risk of drug-induced
long QT syndrome have been conducted using heterologous systems express-
ing the hERG 1a subunit, yet both hERG 1a and 1b subunits contribute to the
channels producing the repolarizing current IKr. Previous studies show that
differences in gating in heteromeric 1a/1b vs. homomeric 1a channels mark-
edly increase repolarizing current during the ventricular action potential and
protect against QT prolongation in computational models. We conducted
a pharmacological analysis of 50 compounds targeting hERG channels and se-
lected for their chemical diversity to evaluate differences in sensitivity that
may influence safety margins or contribute to a stratified risk analysis. Exper-
iments were carried out using the IonWorksTM plate-based electrophysiology
device. Non-cumulative, 8-point concentration effect curves were generated,
with each point representing data from 20 to 30 cells. Potency was determined
as IC50 values (˛1/4M) obtained from data normalized to vehicle and 100%
blocking levels and fitted to the Hill equation. To minimize possible sources
of variability, compound potency was assessed using test plates arranged in
alternating columns of 1a and 1a/1b cells. Although most compounds had sim-
ilar potencies at both variants, some surprising differences were observed. For
example, fluoxetine (Prozac) was 6-fold more potent at blocking hERG 1a/1b
compared to 1a channels. The results were robust when compounds were
tested against the hERG 1a and 1a/1b cell lines in parallel, but statistical anal-
ysis encompassing longitudinal variation indicates such differences may not
be sufficient to warrant routine use of hERG 1a/1b in preclinical high through-
put screens. However, our findings have uncovered several important candi-
dates for further risk evaluation as we learn more about native subunit com-
position in different populations or changes in subunit composition during
development.
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hERG potassium channels are critical for cardiac action potential repolariza-
tion. Disruption of channel function by inherited mutations in the gene encod-
ing hERG have been shown to cause type 2 long QT syndrome (LQT2) by
perturbing trafficking, assembly, selectivity and activation gating. To date,
most mutations have been studied in heterologous systems expressing the
hERG 1a subunit, yet both hERG 1a and 1b subunits contribute to the channels
producing the repolarizing current IKr. hERG 1a and 1b subunits are structur-
ally identical except for the N terminal region, which is unique and much
shorter in the 1b subunit. Differences in gating result in markedly increased
repolarizing current in heteromeric 1a/1b vs. homomeric 1a channels during
the ventricular action potential and protect against QT prolongation in compu-
tational models. We examined nonsense mutations giving rise to truncations
at different points in the amino terminus of hERG 1a. Surprisingly, these
fragments had little or no effect on maturation of hERG 1a and 1b subunits
expressed in HEK-293 cells. Instead, they altered gating and increased rectifi-
cation as if the channels were homomers of hERG 1a subunits. Thus, by ‘‘com-
plementing’’ the hERG 1b subunit (and its short N terminus), the mutant 1a
fragments reduce the repolarization capability of the channel and mediate
a novel mechanism of type 2 long QT syndrome.
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The Human Ether-a´-go-go Related Gene (hERG) encodes a voltage-activated
Kþ channel. hERG contributes to repolarization of the ventricular action po-
tential as the primary component of the cardiac delayed rectifier Kþ current
(IKr) and has also been shown to modulate neuronal firing frequency. hERG
gating is characterized by rapid inactivation upon depolarization and rapid re-
covery from inactivation and slow closing (deactivation) upon repolarization.
These factors combine to create a resurgent hERG current, where the amplitude
of the current is paradoxically larger with repolarization than with depolariza-
tion. These gating transitions also determine the timing and amplitude of the
resurgent current. Previous data has suggested that the hERG N-terminus reg-
ulates gating kinetics, however the molecular mechanisms are not fully under-
stood. Deletion of the N-terminus (amino acids 2-354) has been shown to speed
channel deactivation and recovery from inactivation compared to that of wild-
type hERG. Relative outward current amplitude is also increased during the de-
polarization phase of N-truncated channels, leading to reduced current
